Buchumschlag

BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma

To examine the association between level and patterns of baseline intra-tumoural BRAFV600E protein expression and clinical outcome of BRAFV600E melanoma patients treated with selective BRAF inhibitors.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wilmott, James (VerfasserIn) , Menzies, A. M. (VerfasserIn) , Haydu, L. E. (VerfasserIn) , Capper, David (VerfasserIn) , Preusser, Matthias (VerfasserIn) , Zhang, Y. E. (VerfasserIn) , Thompson, J. F. (VerfasserIn) , Kefford, R. F. (VerfasserIn) , Deimling, Andreas von (VerfasserIn) , Scolyer, R. A. (VerfasserIn) , Long, G. V. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 12 February 2013
In: British journal of cancer
Year: 2013, Jahrgang: 108, Heft: 4, Pages: 924-931
ISSN:1532-1827
DOI:10.1038/bjc.2013.29
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/bjc.2013.29
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/bjc201329
Volltext
Verfasserangaben:J.S. Wilmott, A.M. Menzies, L.E. Haydu, D. Capper, M. Preusser, Y.E. Zhang, J.F. Thompson, R.F. Kefford, A. von Deimling, R.A. Scolyer and G.V. Long

MARC

LEADER 00000caa a2200000 c 4500
001 1777411955
003 DE-627
005 20220820074311.0
007 cr uuu---uuuuu
008 211115s2013 xx |||||o 00| ||eng c
024 7 |a 10.1038/bjc.2013.29  |2 doi 
035 |a (DE-627)1777411955 
035 |a (DE-599)KXP1777411955 
035 |a (OCoLC)1341423841 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Wilmott, James  |e VerfasserIn  |0 (DE-588)1245806920  |0 (DE-627)1777413346  |4 aut 
245 1 0 |a BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma  |c J.S. Wilmott, A.M. Menzies, L.E. Haydu, D. Capper, M. Preusser, Y.E. Zhang, J.F. Thompson, R.F. Kefford, A. von Deimling, R.A. Scolyer and G.V. Long 
246 3 3 |a BRAF V600E protein expression and outcome from BRAF inhibitor treatment in BRAF V600E metastatic melanoma 
264 1 |c 12 February 2013 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Im Titel ist "V600E" jeweils hochgestellt 
500 |a Gesehen am 15.11.2021 
520 |a To examine the association between level and patterns of baseline intra-tumoural BRAFV600E protein expression and clinical outcome of BRAFV600E melanoma patients treated with selective BRAF inhibitors. 
650 4 |a Melanoma 
650 4 |a Targeted therapies 
650 4 |a Tumour biomarkers 
700 1 |a Menzies, A. M.  |e VerfasserIn  |4 aut 
700 1 |a Haydu, L. E.  |e VerfasserIn  |4 aut 
700 1 |a Capper, David  |d 1979-  |e VerfasserIn  |0 (DE-588)133950751  |0 (DE-627)558829902  |0 (DE-576)300212402  |4 aut 
700 1 |a Preusser, Matthias  |d 1976-  |e VerfasserIn  |0 (DE-588)1156333008  |0 (DE-627)1019103949  |0 (DE-576)502110627  |4 aut 
700 1 |a Zhang, Y. E.  |e VerfasserIn  |4 aut 
700 1 |a Thompson, J. F.  |e VerfasserIn  |4 aut 
700 1 |a Kefford, R. F.  |e VerfasserIn  |4 aut 
700 1 |a Deimling, Andreas von  |d 1959-  |e VerfasserIn  |0 (DE-588)103034115X  |0 (DE-627)735093946  |0 (DE-576)378138065  |4 aut 
700 1 |a Scolyer, R. A.  |e VerfasserIn  |4 aut 
700 1 |a Long, G. V.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t British journal of cancer  |d Edinburgh : Nature Publ. Group, 1947  |g 108(2013), 4, Seite 924-931  |h Online-Ressource  |w (DE-627)320420094  |w (DE-600)2002452-6  |w (DE-576)103746854  |x 1532-1827  |7 nnas  |a BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma 
773 1 8 |g volume:108  |g year:2013  |g number:4  |g pages:924-931  |g extent:8  |a BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma 
856 4 0 |u https://doi.org/10.1038/bjc.2013.29  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/bjc201329  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20211115 
993 |a Article 
994 |a 2013 
998 |g 103034115X  |a Deimling, Andreas von  |m 103034115X:Deimling, Andreas von  |d 910000  |d 912000  |e 910000PD103034115X  |e 912000PD103034115X  |k 0/910000/  |k 1/910000/912000/  |p 9 
998 |g 133950751  |a Capper, David  |m 133950751:Capper, David  |d 910000  |d 912000  |e 910000PC133950751  |e 912000PC133950751  |k 0/910000/  |k 1/910000/912000/  |p 4 
999 |a KXP-PPN1777411955  |e 4002097196 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Im Titel ist \"V600E\" jeweils hochgestellt","Gesehen am 15.11.2021"],"titleAlt":[{"title":"BRAF V600E protein expression and outcome from BRAF inhibitor treatment in BRAF V600E metastatic melanoma"}],"language":["eng"],"person":[{"given":"James","display":"Wilmott, James","family":"Wilmott","role":"aut"},{"role":"aut","family":"Menzies","display":"Menzies, A. M.","given":"A. M."},{"given":"L. E.","display":"Haydu, L. E.","family":"Haydu","role":"aut"},{"given":"David","family":"Capper","role":"aut","display":"Capper, David"},{"given":"Matthias","display":"Preusser, Matthias","role":"aut","family":"Preusser"},{"given":"Y. E.","family":"Zhang","role":"aut","display":"Zhang, Y. E."},{"given":"J. F.","role":"aut","family":"Thompson","display":"Thompson, J. F."},{"family":"Kefford","role":"aut","display":"Kefford, R. F.","given":"R. F."},{"given":"Andreas von","role":"aut","family":"Deimling","display":"Deimling, Andreas von"},{"given":"R. A.","role":"aut","family":"Scolyer","display":"Scolyer, R. A."},{"display":"Long, G. V.","family":"Long","role":"aut","given":"G. V."}],"recId":"1777411955","id":{"doi":["10.1038/bjc.2013.29"],"eki":["1777411955"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["J.S. Wilmott, A.M. Menzies, L.E. Haydu, D. Capper, M. Preusser, Y.E. Zhang, J.F. Thompson, R.F. Kefford, A. von Deimling, R.A. Scolyer and G.V. Long"]},"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"12 February 2013"}],"relHost":[{"title":[{"title":"British journal of cancer","title_sort":"British journal of cancer","subtitle":"BJC"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"volume":"108","text":"108(2013), 4, Seite 924-931","extent":"8","issue":"4","year":"2013","pages":"924-931"},"language":["eng"],"pubHistory":["Volume 1, issue 1 (1 March 1947)-"],"titleAlt":[{"title":"BJC"}],"note":["Gesehen am 27.10.25"],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"issn":["1532-1827"],"eki":["320420094"],"zdb":["2002452-6"]},"recId":"320420094","origin":[{"publisherPlace":"Edinburgh ; Edinburgh","dateIssuedKey":"1947","dateIssuedDisp":"1947-","publisher":"Nature Publ. Group ; Churchill Livingstone"}],"disp":"BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanomaBritish journal of cancer"}],"physDesc":[{"extent":"8 S."}],"title":[{"title":"BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma","title_sort":"BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma"}]} 
SRT |a WILMOTTJAMBRAFV600EP1220 

Ähnliche Einträge